Free Trial
NASDAQ:GRAL

Grail (GRAL) Stock Price, News & Analysis

Grail logo
$39.56 +0.24 (+0.62%)
As of 11:26 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Grail Stock (NASDAQ:GRAL)

Key Stats

Today's Range
$38.08
$39.82
50-Day Range
$21.39
$42.89
52-Week Range
$12.33
$63.99
Volume
196,897 shs
Average Volume
1.25 million shs
Market Capitalization
$1.42 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$31.50
Consensus Rating
Hold

Company Overview

GRAIL, Inc. operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T. Huber, William H. Rastetter, Mostafa Ronaghi, and Richard D. Klausner on September 11, 2015 and is headquartered in Menlo Park, CA.

Grail Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
16th Percentile Overall Score

GRAL MarketRank™: 

Grail scored higher than 16% of companies evaluated by MarketBeat, and ranked 863rd out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Grail has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on 1 buy rating, 3 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Grail has only been the subject of 2 research reports in the past 90 days.

  • Read more about Grail's stock forecast and price target.
  • Earnings Growth

    Earnings for Grail are expected to grow in the coming year, from ($15.15) to ($12.95) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Grail is -0.64, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Grail is -0.64, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Percentage of Shares Shorted

    19.18% of the float of Grail has been sold short.
  • Short Interest Ratio / Days to Cover

    Grail has a short interest ratio ("days to cover") of 3.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Grail has recently increased by 3.90%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Grail does not currently pay a dividend.

  • Dividend Growth

    Grail does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    19.18% of the float of Grail has been sold short.
  • Short Interest Ratio / Days to Cover

    Grail has a short interest ratio ("days to cover") of 3.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Grail has recently increased by 3.90%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Grail has a news sentiment score of 1.29. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.65 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 17 news articles for Grail this week, compared to 7 articles on an average week.
  • Search Interest

    21 people have searched for GRAL on MarketBeat in the last 30 days. This is an increase of 110% compared to the previous 30 days.
  • MarketBeat Follows

    11 people have added Grail to their MarketBeat watchlist in the last 30 days. This is an increase of 83% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Grail insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $6,583,130.00 in company stock.

  • Percentage Held by Insiders

    Only 1.85% of the stock of Grail is held by insiders.

  • Read more about Grail's insider trading history.
Receive GRAL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Grail and its competitors with MarketBeat's FREE daily newsletter.

GRAL Stock News Headlines

While others chase AI stocks, smart traders do this
Since the pandemic, the average mortgage payment has jumped from $1,427 to $2,047. That's an extra $600 every single month just vanishing from people's pockets. Meanwhile, credit card debt is hitting record highs, and savings accounts are at their lowest since 2008. Most folks are left with two options… Get a second job... or work overtime on weekends. But what if there was a third option? I just uncovered a shocking anomaly in the options market that could change everything... One that lets you target extra cash on days when most people make nothing - weekends. Think what that could mean for your monthly budget...
Head to Head Contrast: Grail (GRAL) & Its Competitors
Grail (GRAL) vs. The Competition Financial Survey
See More Headlines

GRAL Stock Analysis - Frequently Asked Questions

Grail's stock was trading at $17.85 at the start of the year. Since then, GRAL stock has increased by 120.3% and is now trading at $39.32.
View the best growth stocks for 2025 here
.

Grail, Inc. (NASDAQ:GRAL) posted its earnings results on Tuesday, May, 13th. The company reported ($3.10) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($4.03) by $0.93. The firm had revenue of $31.84 million for the quarter, compared to the consensus estimate of $35.80 million.
Read the conference call transcript
.

Grail's top institutional shareholders include Primecap Management Co. CA (5.81%), Sessa Capital IM L.P. (5.43%), Vanguard Group Inc. (4.25%) and AQR Capital Management LLC (3.79%). Insiders that own company stock include Chun R Ding, Robert P Ragusa, Joshua J Ofman and Aaron Freidin.
View institutional ownership trends
.

Shares of GRAL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Grail investors own include NVIDIA (NVDA), Tesla (TSLA), Advanced Micro Devices (AMD), Meta Platforms (META), Netflix (NFLX), JPMorgan Chase & Co. (JPM) and Visa (V).

Company Calendar

Last Earnings
5/13/2025
Today
5/21/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical laboratories
Sub-Industry
Healthcare
Current Symbol
NASDAQ:GRAL
Previous Symbol
NASDAQ:GRAL
Web
N/A
Fax
N/A
Employees
1,360
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$31.50
High Stock Price Target
$43.00
Low Stock Price Target
$20.00
Potential Upside/Downside
-19.9%
Consensus Rating
Hold
Rating Score (0-4)
2.25
Research Coverage
4 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$130.71 million
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$1.41 billion
Optionable
Optionable
Beta
N/A
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report

This page (NASDAQ:GRAL) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners